In this episode, VibeCast host Ray Dogum speaks with Roy de Souza, Founder and CEO of BreakBio, about personalized cancer treatments.

--------------------------------------------------------------------------------------------
The key moments in this episode are:
00:00:07 - Introduction to Vibecast
00:01:01 - Roy de Souza's Journey into Cancer Care and Biotech
00:04:21 - Exploring Theories of Cancer
00:06:32 - Problem Solving in Cancer Treatment
00:12:57 - BreakBio's Drug Pipeline
00:14:41 - Breakthrough Therapy Designation and Target Indications
00:15:33 - The Power of T Cells in Targeting Solid Tumors
00:17:48 - Combination Therapy and FDA Approval
00:20:29 - Patient Treatment Timeline
00:22:11 - Leveraging AI and Machine Learning
00:28:55 - The Importance of Colon Cancer Vaccines
00:29:42 - Funding Landscape in the Biotech Industry
00:30:44 - Seeking Partnerships
00:32:42 - Future Outlook

Guest Bio:
Roy de Souza is solving a big problem of our lifetimes: curing solid cancers. BreakBio uses AI/ML to find 30 targets on a patient’s cancer cells from various patient data sets especially mass spectrometry per patient (an industry first). Mass spectrometry provides accurate AI training per patient. It then manufactures a 30 peptide personalized immunotherapy which is also known as a cancer vaccine. Clinical trials in the first indication are starting this year at top academic centres like MD Anderson. Roy received a Masters in Engineering at Oxford, an MBA from the Kellogg School and worked for Elon Musk's first company. He founded ZEDO Inc. that became the 3rd largest ad server in the world and used AI to determine which user sees which ad. He sold ZEDO to Warner Bros Discovery, the world's largest media company which owns CNN and HBO.
Roy became determined to get to cures when his wife was diagnosed with colon cancer in 2017. She later passed away. He has 3 young children and is moving to Miami, FL. He is also a Director of SaveGroundwater.org in India and loves skiing and audiobook

Guest Links:
Linkedin: http://linkedin.com/in/roydesouza
Twitter: https://twitter.com/roydesouza
BreakBio Website: https://breakbio.com/

About VibeCast
VibeCast is our weekly informational podcast and content series exploring the hottest topics in drug development and Web3 with some of the dynamic people that make up the Vibe community. VibeCast is a collection of long-form and short-form video content intended to help our community learn about the current opportunities and challenges in biotech fundraising and community engagement innovation.

Guests include biotech founders, regulatory experts, drug development executives, blockchain technologists, web3 community builders, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments.

Follow Vibe Bio's Socials:
https://twitter.com/VibeBio
https://www.linkedin.com/company/vibe-bio/
https://www.instagram.com/vibebiotechnology/
https://www.tiktok.com/@vibebio
https://www.facebook.com/VibeBiotechnology/

Disclaimer: VibeCast is intended to be used for educational and entertainment purposes, and no information or opinions shared constitute advice or services. While guests are invited to listen, listeners acknowledge they are not being provided professional advice from the podcast or the guests. The podcast is for private non-commercial use and the statements of our guests reflect their personal views only and do not necessarily reflect the views or positions of any agency, organization, or company that they work for or are affiliated with.